Merck & Co., Inc. (NYSE:MRK)

As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction

Friday brought on major selling in the stock market, with the Dow Jones industrials down over 400 points and the S&P 500 down almost 50 points earlier in the ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

5 Safe Merrill Lynch US 1 List Stocks to Buy That Pay Big Dividends

With earnings reports for the fourth quarter all but over, and the second quarter of 2019 well underway, many of the top companies we follow on Wall Street are making ...
Read Full Story »

Major Pharma Sees Tremendous Rise in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

Stocks were indicated to open higher by over 100 points on the Dow Jones industrial average and 10 points on the S&P 500 on developing China trade hopes. With the ...
Read Full Story »

Is Merck Overpaying for Immune Design?

Immune Design Corp. (NASDAQ: IMDZ) shares absolutely exploded on Thursday after Merck & Co. Inc. (NYSE: MRK) announced that it would be acquiring the firm at what some might call ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Air, S&P, Transocean, Walmart and More

Stocks were indicated to open marginally lower on Wednesday, but the Dow Jones industrials had risen about 3,000 points from the lows of early January. Now investors need to be ...
Read Full Story »

Major Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 15 Best Dividend Stocks for Retirees to Own

There are many types of investors in America. Whether you are in your twenties or retired, it is important to know what strategy is the best fit for your portfolio. ...
Read Full Story »

Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List

With earnings reporting for the fourth quarter more than half over, and the first quarter of 2019 about the same, many of the top companies we follow on Wall Street ...
Read Full Story »

Merck Clears a Low Hurdle for Q4 Earnings

When Merck & Co., Inc. (NYSE: MRK) released its fourth-quarter financial results after the markets closed on Thursday, the pharma giant said that it had $1.04 in earnings per share ...
Read Full Story »

What to Expect When Merck Reports on Friday

Merck & Co Inc. (NYSE: MRK) is scheduled to release its fourth-quarter report before the markets open on Friday. This was the best performing Dow Jones industrial stock of 2018 ...
Read Full Story »

Short Interest Spikes in a Couple Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

Most of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. Coming this week are 12 of the 30 Dow components. The Dow ...
Read Full Story »

How the 30 Dow Stocks Are Doing in 2019

As 2019 unfolds, one question is likely on most investors’ minds: Is the bull market that began in March 2009 dead, or can it find its footing on less stable ...
Read Full Story »